• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Younger Patients More Affected by Neurologic Manifestations of Long COVID

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 22, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Nov. 22, 2024 -- Younger and middle-aged patients seem to be disproportionately affected by neurologic manifestations of postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (Neuro-PASC), according to a study published online Nov. 22 in the Annals of Neurology.

Natasha A. Choudhury, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues conducted a cross-sectional study of the first consecutive 200 posthospitalization Neuro-PASC and 1,100 nonhospitalized Neuro-PASC (NNP) patients assessed at a Neuro-COVID-19 clinic between May 2020 and March 2023. Patients were divided into age groups: younger, middle-aged, and older (18 to 44, 45 to 64, and 65-plus years, respectively).

The researchers found that significant age-related differences in the frequencies of comorbidities and abnormal neurologic findings demonstrated higher prevalence in older patients. Conversely, significant age-related differences in Neuro-PASC symptoms, indicating lower prevalence and symptom burden in older individuals, were seen at 10 months from COVID-19 onset. In the NNP group, there were significant age-related differences observed in subjective impression of fatigue and sleep disturbance, corresponding with higher impairment in quality of life for younger patients. In NNP patients, significant age-related differences were seen in objective executive function and working memory, with the worst performance seen in younger patients.

"The impact of this condition causing disproportionate morbidity and disability in younger adults in their prime, who provide much of the workforce, productivity, and innovation in our society, may lead to critical issues of increased health care system burden, mental health crisis, socio-cultural deterioration, and economic recession," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted November 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.